Livforsakringsbolaget Skandia, Omsesidigt Biogen Inc. Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

$1.85 Billion
Q4 2024

A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Biogen Inc. stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 1,430 shares of BIIB stock, worth $208,107. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,430

Previous 1,430 -0.0%

Holding current value

$208,107

Previous $277,000 21.3%

% of portfolio

0.01%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$189.07 - $236.8 $226,884 - $284,160	1,200 Added 521.74%	1,430 $277,000
Q2 2024 Jul 15, 2024	SELL	$190.52 - $236.72 $38,104 - $47,344	-200 Reduced 46.51%	230 $53,000
Q4 2023 Jan 31, 2024	BUY	$222.59 - $267.94 $58,541 - $70,468	263 Added 157.49%	430 $111,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $175,221 - $241,613	-900 Reduced 84.35%	167 $45,000
Q2 2022 Aug 16, 2022	SELL	$187.54 - $223.02 $1.15 Million - $1.36 Million	-6,120 Reduced 85.15%	1,067 $218,000
Q1 2022 Jun 21, 2022	SELL	$193.77 - $244.14 $2.69 Million - $3.39 Million	-13,900 Reduced 65.92%	7,187 $1.51 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $201,528 - $258,992	-900 Reduced 4.09%	21,087 $5.06 Million
Q3 2021 Oct 28, 2021	SELL	$282.99 - $369.05 $56,598 - $73,810	-200 Reduced 0.9%	21,987 $6.22 Million
Q2 2021 Jul 13, 2021	BUY	$259.0 - $414.71 $259,000 - $414,710	1,000 Added 4.72%	22,187 $7.68 Million
Q1 2021 May 07, 2021	SELL	$242.95 - $284.63 $72,885 - $85,389	-300 Reduced 1.4%	21,187 $5.93 Million
Q4 2020 Mar 02, 2021	BUY	$236.26 - $355.63 $189,008 - $284,504	800 Added 3.87%	21,487 $5.26 Million
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $105,908 - $122,283	-400 Reduced 1.9%	20,687 $5.87 Million
Q2 2020 Jul 08, 2020	BUY	$258.66 - $342.55 $905,310 - $1.2 Million	3,500 Added 19.9%	21,087 $5.64 Million
Q1 2020 Apr 22, 2020	BUY	$268.85 - $341.04 $134,425 - $170,520	500 Added 2.93%	17,587 $5.56 Million
Q4 2019 Jan 28, 2020	SELL	$220.06 - $304.07 $176,048 - $243,256	-800 Reduced 4.47%	17,087 $5.07 Million
Q2 2019 Jul 19, 2019	BUY	$219.29 - $241.72 $65,787 - $72,516	300 Added 1.71%	17,887 $4.18 Million
Q3 2018 Oct 26, 2018	SELL	$293.51 - $383.83 $1.5 Million - $1.96 Million	-5,100 Reduced 22.48%	17,587 $6.21 Million
Q2 2018 Jul 10, 2018	BUY	$257.52 - $306.91 $103,008 - $122,764	400 Added 1.79%	22,687 $6.58 Million
Q1 2018 Apr 11, 2018	BUY	$260.13 - $367.91 $494,247 - $699,029	1,900 Added 9.32%	22,287 $357,000
Q4 2017 Jan 18, 2018	SELL	$307.64 - $344.58 $676,808 - $758,076	-2,200 Reduced 9.74%	20,387 $6.5 Million
Q3 2017 Oct 12, 2017	BUY	$281.15 - $329.69 $6.35 Million - $7.45 Million	22,587	22,587 $7.07 Million

Others Institutions Holding BIIB

# of Institutions

995

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.

Account

Livforsakringsbolaget Skandia, Omsesidigt Biogen Inc. Transaction History